organic compounds\(\def\hfill{\hskip 5em}\def\hfil{\hskip 3em}\def\eqno#1{\hfil {#1}}\)

Journal logoCRYSTALLOGRAPHIC
COMMUNICATIONS
ISSN: 2056-9890

Crystal structure of 3-bromo­methyl-2-chloro-6-(di­bromo­meth­yl)quinoline

aDepartment of Chemistry, Bharathiar University, Coimbatore 641 046, Tamil Nadu, India, bDepartment of Chemistry, University of Durham, South Road, Durham DH1 3LE, England, and cUniveristy of Bristol, Department of Chemistry, Cantock's Close, Bristol BS8 1TS, England
*Correspondence e-mail: psmohan59@gmail.com

Edited by H. Stoeckli-Evans, University of Neuchâtel, Switzerland (Received 18 March 2015; accepted 22 April 2015; online 30 April 2015)

In the title compound, C11H7Br3ClN, the quinoline ring system is approximately planar (r.m.s. = 0.011 Å). In the crystal, mol­ecules are linked by C—H⋯Br inter­actions forming chains along [10-1]. The chains are linked by C—H⋯π and ππ inter­actions involving inversion-related pyridine rings [inter­centroid distance = 3.608 (4) Å], forming sheets parallel to (10-1). Within the sheets, there are two significant short inter­actions involving a Br⋯Cl contact of 3.4904 (18) Å and a Br⋯N contact of 3.187 (6) Å, both of which are significantly shorter than the sum of their van der Waals radii.

1. Related literature

The title compound is an important inter­mediate in the manufacture of materials such as organic light-emitting devices. For the synthesis of the title compound, see: Jones (1977[Jones, G. (1977). Quinolines, Part-I. Wiley Interscience Publication, John Wiley & Sons.]); Lyle et al. (1972[Lyle, R. E., Portlock, D. E., Kane, M. J. & Bristol, J. A. (1972). J. Org. Chem. 37, 3967-3968.]). For the biological activity of quinoline derivatives, see: Chauhan & Srivastava (2001[Chauhan, P. M. S. & Srivastava, S. K. (2001). Curr. Med. Chem. 8, 1535-1542.]); Ferrarini et al. (2000[Ferrarini, P. L., Mori, C., Badawneh, M., Calderone, V., Greco, R., Manera, C., Martinelli, A., Nieri, P. & Saccomanni, G. (2000). Eur. J. Med. Chem. 35, 815-826.]); Chen et al. (2001[Chen, Y. L., Fang, K. C., Sheu, J. Y., Hsu, S. L. & Tzeng, C. C. (2001). J. Med. Chem. 44, 2374-2377.]); Sahin et al. (2008[Sahin, A., Cakmak, O., Demirtas, I., Okten, S. & Tutar, A. (2008). Tetrahedron, 64, 10068-10074.]).

[Scheme 1]

2. Experimental

2.1. Crystal data

  • C11H7Br3ClN

  • Mr = 428.36

  • Monoclinic, P 21 /n

  • a = 8.9042 (5) Å

  • b = 9.3375 (4) Å

  • c = 15.5107 (7) Å

  • β = 104.553 (5)°

  • V = 1248.23 (11) Å3

  • Z = 4

  • Mo Kα radiation

  • μ = 9.88 mm−1

  • T = 120 K

  • 0.42 × 0.36 × 0.30 mm

2.2. Data collection

  • Oxford Diffraction Xcalibur Sapphire3 Gemini ultra diffractometer

  • Absorption correction: analytical (CrysAlis PRO; Oxford Diffraction, 2010[Oxford Diffraction (2010). CrysAlis PRO. Oxford Diffraction Ltd, Yarnton, England.]) Tmin = 0.056, Tmax = 0.153

  • 8597 measured reflections

  • 2259 independent reflections

  • 1889 reflections with I > 2σ(I)

  • Rint = 0.029

2.3. Refinement

  • R[F2 > 2σ(F2)] = 0.051

  • wR(F2) = 0.143

  • S = 1.09

  • 2259 reflections

  • 145 parameters

  • H-atom parameters constrained

  • Δρmax = 1.65 e Å−3

  • Δρmin = −1.19 e Å−3

Table 1
Hydrogen-bond geometry (Å, °)

Cg2 is the centroid of the C4–C9 ring.

D—H⋯A D—H H⋯A DA D—H⋯A
C11—H11⋯Br1i 1.00 2.92 3.709 (8) 137
C10—H10BCg2ii 0.99 2.70 3.438 (8) 131
Symmetry codes: (i) [x-{\script{1\over 2}}, -y+{\script{1\over 2}}, z-{\script{1\over 2}}]; (ii) -x+1, -y+1, -z+1.

Data collection: CrysAlis PRO (Oxford Diffraction, 2010[Oxford Diffraction (2010). CrysAlis PRO. Oxford Diffraction Ltd, Yarnton, England.]); cell refinement: CrysAlis PRO; data reduction: CrysAlis PRO; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); program(s) used to refine structure: SHELXL2014 (Sheldrick, 2015[Sheldrick, G. M. (2015). Acta Cryst. C71, 3-8.]); molecular graphics: PLATON (Spek, 2009[Spek, A. L. (2009). Acta Cryst. D65, 148-155.]) and Mercury (Macrae et al., 2008[Macrae, C. F., Bruno, I. J., Chisholm, J. A., Edgington, P. R., McCabe, P., Pidcock, E., Rodriguez-Monge, L., Taylor, R., van de Streek, J. & Wood, P. A. (2008). J. Appl. Cryst. 41, 466-470.]); software used to prepare material for publication: SHELXL2014 and PLATON.

Supporting information


Synthesis and crystallization top

The title compound was prepared in line with literature methods (Jones, 1977; Lyle et al., 1972). 2-Chloro-3,6-di­methyl-quinoline (0.001 mole) was dissolved in CCl4. To this benzoyl peroxide (50 mg) was added and the mixture was stirred under ice-cold conditions. To this mixture N-bromo­succinimide (0.005 mole) was added portion wise. The whole mixture was further stirred under ice-cold condition for 1 h. The reaction mixture was then refluxed for about 10 hours. After completion of the reaction, the succinimide was removed (it was insoluble in CCl4) by filtration and washed with 20 ml of CCl4. The contents of the filtrate were reduced to half, and the residue was chromatographed on silica gel using petroleum ether and ethyl acetate as eluent (99:1), which gave the titled product (yield: 52%). The white solid obtained was then recrystallized using acetone yielding colourless block-like crystals.

Refinement top

Crystal data, data collection and structure refinement details are summarized in Table 1. H atoms were included in calculated positions and refined using a riding model: C—H = 0.95 - 1.0 Å with Uiso(H) = 1.2Ueq(C). The highest peak in the final difference Fourier map (1.654 eÅ-3) is close to atom Cl1. Attempts to split this atom were unsuccessful.

Structural commentary top

The presence of the quinoline skeleton in the frameworks of pharmacologically active compounds and natural products has spurred on the development of different strategies for their synthesis (Chauhan et al., 2001; Ferrarini et al., 2000; Chen et al., 2001). Bromo­quinolines have been of inter­est for chemists as precursors for heterocyclic compounds with multifunctionality, giving accessibility to a wide variety of compounds. These building blocks have been used in medicinal chemistry as starting materials for numerous compounds with pharmacological activity (Sahin et al., 2008).

The molecular structure of the title compound is shown in Fig. 1. The quinoline ring is planar (r.m.s. = 0.011 Å).

In the crystal, molecules are linked by C—H···Br inter­actions forming chains along [101]; Table 1 and Fig. 2. The chains are linked by C—H···π (Table 1), and π-π inter­actions involving inversion related pyridine rings (N1/C1—C5) with an inter-centroid distance of 3.608 (4) Å, forming sheets parallel to (101). Within the sheets, there are two significant short inter­actions: A Br1···Cli contact of 3.4904 (18) Å and a Br3···Nii contact of 3.187 (6) Å [symmetry codes: (i) -x+3/2, y-1/2, -z+3/2; (ii) x-1/2, -y+3/2, z-1/2], both are significantly shorter than the sum of their van der Waals radii [1.85 Å for Br; 1.75 Å for Cl; 1.55 Å for N; PLATON (Spek, 2009)].

Related literature top

The title compound is an important intermediate in the manufacture of materials such as organic light-emitting devices. For the synthesis of the title compound, see: Jones (1977); Lyle et al. (1972). For the biological activity of quinoline derivatives, see: Chauhan & Srivastava (2001); Ferrarini et al. (2000); Chen et al. (2001); Sahin et al. (2008).

Structure description top

The presence of the quinoline skeleton in the frameworks of pharmacologically active compounds and natural products has spurred on the development of different strategies for their synthesis (Chauhan et al., 2001; Ferrarini et al., 2000; Chen et al., 2001). Bromo­quinolines have been of inter­est for chemists as precursors for heterocyclic compounds with multifunctionality, giving accessibility to a wide variety of compounds. These building blocks have been used in medicinal chemistry as starting materials for numerous compounds with pharmacological activity (Sahin et al., 2008).

The molecular structure of the title compound is shown in Fig. 1. The quinoline ring is planar (r.m.s. = 0.011 Å).

In the crystal, molecules are linked by C—H···Br inter­actions forming chains along [101]; Table 1 and Fig. 2. The chains are linked by C—H···π (Table 1), and π-π inter­actions involving inversion related pyridine rings (N1/C1—C5) with an inter-centroid distance of 3.608 (4) Å, forming sheets parallel to (101). Within the sheets, there are two significant short inter­actions: A Br1···Cli contact of 3.4904 (18) Å and a Br3···Nii contact of 3.187 (6) Å [symmetry codes: (i) -x+3/2, y-1/2, -z+3/2; (ii) x-1/2, -y+3/2, z-1/2], both are significantly shorter than the sum of their van der Waals radii [1.85 Å for Br; 1.75 Å for Cl; 1.55 Å for N; PLATON (Spek, 2009)].

The title compound is an important intermediate in the manufacture of materials such as organic light-emitting devices. For the synthesis of the title compound, see: Jones (1977); Lyle et al. (1972). For the biological activity of quinoline derivatives, see: Chauhan & Srivastava (2001); Ferrarini et al. (2000); Chen et al. (2001); Sahin et al. (2008).

Synthesis and crystallization top

The title compound was prepared in line with literature methods (Jones, 1977; Lyle et al., 1972). 2-Chloro-3,6-di­methyl-quinoline (0.001 mole) was dissolved in CCl4. To this benzoyl peroxide (50 mg) was added and the mixture was stirred under ice-cold conditions. To this mixture N-bromo­succinimide (0.005 mole) was added portion wise. The whole mixture was further stirred under ice-cold condition for 1 h. The reaction mixture was then refluxed for about 10 hours. After completion of the reaction, the succinimide was removed (it was insoluble in CCl4) by filtration and washed with 20 ml of CCl4. The contents of the filtrate were reduced to half, and the residue was chromatographed on silica gel using petroleum ether and ethyl acetate as eluent (99:1), which gave the titled product (yield: 52%). The white solid obtained was then recrystallized using acetone yielding colourless block-like crystals.

Refinement details top

Crystal data, data collection and structure refinement details are summarized in Table 1. H atoms were included in calculated positions and refined using a riding model: C—H = 0.95 - 1.0 Å with Uiso(H) = 1.2Ueq(C). The highest peak in the final difference Fourier map (1.654 eÅ-3) is close to atom Cl1. Attempts to split this atom were unsuccessful.

Computing details top

Data collection: CrysAlis PRO (Oxford Diffraction, 2010); cell refinement: CrysAlis PRO (Oxford Diffraction, 2010); data reduction: CrysAlis PRO (Oxford Diffraction, 2010); program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: SHELXL2014 (Sheldrick, 2015); molecular graphics: PLATON (Spek, 2009) and Mercury (Macrae et al., 2008); software used to prepare material for publication: SHELXL2014 (Sheldrick, 2015) and PLATON (Spek, 2009).

Figures top
[Figure 1] Fig. 1. The molecular structure of the title compound, with atom labelling. Displacement ellipsoids are drawn at the 50% probability level.
[Figure 2] Fig. 2. A view along the a axis of the crystal packing of the title compound. The C—H···Br hydrogen bonds, C—H···π interactions (Table 1) and the Br···Cl and Br···N short contacts are shown as dashed lines.
3-Bromomethyl-2-chloro-6-(dibromomethyl)quinoline top
Crystal data top
C11H7Br3ClNF(000) = 808
Mr = 428.36Dx = 2.279 Mg m3
Monoclinic, P21/nMo Kα radiation, λ = 0.71073 Å
a = 8.9042 (5) ÅCell parameters from 4382 reflections
b = 9.3375 (4) Åθ = 2.6–29.0°
c = 15.5107 (7) ŵ = 9.88 mm1
β = 104.553 (5)°T = 120 K
V = 1248.23 (11) Å3Block, colourless
Z = 40.42 × 0.36 × 0.30 mm
Data collection top
Oxford Diffraction Xcalibur Sapphire3 Gemini ultra
diffractometer
2259 independent reflections
Radiation source: Enhance (Mo) X-ray Source1889 reflections with I > 2σ(I)
Graphite monochromatorRint = 0.029
Detector resolution: 16.1511 pixels mm-1θmax = 25.3°, θmin = 2.4°
ω scansh = 1010
Absorption correction: analytical
(CrysAlis PRO; Oxford Diffraction, 2010)
k = 1111
Tmin = 0.056, Tmax = 0.153l = 1812
8597 measured reflections
Refinement top
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullSecondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.051Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.143H-atom parameters constrained
S = 1.09 w = 1/[σ2(Fo2) + (0.0713P)2 + 10.6242P]
where P = (Fo2 + 2Fc2)/3
2259 reflections(Δ/σ)max < 0.001
145 parametersΔρmax = 1.65 e Å3
0 restraintsΔρmin = 1.19 e Å3
Crystal data top
C11H7Br3ClNV = 1248.23 (11) Å3
Mr = 428.36Z = 4
Monoclinic, P21/nMo Kα radiation
a = 8.9042 (5) ŵ = 9.88 mm1
b = 9.3375 (4) ÅT = 120 K
c = 15.5107 (7) Å0.42 × 0.36 × 0.30 mm
β = 104.553 (5)°
Data collection top
Oxford Diffraction Xcalibur Sapphire3 Gemini ultra
diffractometer
2259 independent reflections
Absorption correction: analytical
(CrysAlis PRO; Oxford Diffraction, 2010)
1889 reflections with I > 2σ(I)
Tmin = 0.056, Tmax = 0.153Rint = 0.029
8597 measured reflections
Refinement top
R[F2 > 2σ(F2)] = 0.0510 restraints
wR(F2) = 0.143H-atom parameters constrained
S = 1.09 w = 1/[σ2(Fo2) + (0.0713P)2 + 10.6242P]
where P = (Fo2 + 2Fc2)/3
2259 reflectionsΔρmax = 1.65 e Å3
145 parametersΔρmin = 1.19 e Å3
Special details top

Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes.

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2) top
xyzUiso*/Ueq
Br10.63474 (10)0.04489 (9)0.60991 (6)0.0370 (3)
Br30.45280 (10)0.74291 (9)0.12751 (6)0.0381 (3)
Br20.70035 (11)0.53886 (11)0.08299 (6)0.0429 (3)
Cl10.8069 (2)0.38929 (19)0.67965 (10)0.0226 (4)
N10.7951 (7)0.4817 (7)0.5207 (4)0.0242 (13)
C10.7245 (8)0.3973 (8)0.5630 (4)0.0215 (15)
C20.5903 (8)0.3156 (7)0.5249 (4)0.0179 (14)
C30.5309 (8)0.3292 (7)0.4361 (5)0.0201 (14)
H30.44110.27630.40740.024*
C40.6012 (8)0.4213 (7)0.3857 (4)0.0175 (14)
C50.7359 (8)0.4957 (8)0.4305 (5)0.0197 (14)
C60.8084 (8)0.5892 (9)0.3828 (5)0.0274 (17)
H60.89910.63970.41290.033*
C70.7505 (9)0.6079 (9)0.2946 (5)0.0279 (17)
H70.80020.67220.26310.034*
C80.6160 (8)0.5326 (8)0.2483 (5)0.0217 (15)
C90.5450 (8)0.4423 (7)0.2927 (4)0.0201 (14)
H90.45550.39160.26120.024*
C100.5174 (9)0.2212 (8)0.5792 (5)0.0234 (15)
H10A0.41020.19810.54560.028*
H10B0.51200.27180.63440.028*
C110.5499 (9)0.5552 (8)0.1511 (5)0.0250 (16)
H110.46830.48090.12950.030*
Atomic displacement parameters (Å2) top
U11U22U33U12U13U23
Br10.0423 (5)0.0311 (5)0.0363 (5)0.0018 (4)0.0073 (4)0.0085 (3)
Br30.0415 (5)0.0292 (5)0.0416 (5)0.0098 (4)0.0068 (4)0.0091 (3)
Br20.0437 (5)0.0546 (6)0.0369 (5)0.0031 (4)0.0225 (4)0.0033 (4)
Cl10.0252 (9)0.0296 (9)0.0114 (7)0.0033 (7)0.0013 (6)0.0017 (6)
N10.022 (3)0.025 (3)0.024 (3)0.001 (3)0.003 (2)0.000 (3)
C10.020 (4)0.026 (4)0.018 (3)0.001 (3)0.005 (3)0.001 (3)
C20.019 (3)0.012 (3)0.023 (3)0.002 (3)0.007 (3)0.002 (3)
C30.020 (3)0.012 (3)0.027 (4)0.003 (3)0.004 (3)0.001 (3)
C40.017 (3)0.013 (3)0.024 (3)0.001 (3)0.008 (3)0.002 (3)
C50.019 (3)0.020 (3)0.021 (3)0.002 (3)0.005 (3)0.000 (3)
C60.018 (4)0.030 (4)0.031 (4)0.003 (3)0.000 (3)0.002 (3)
C70.023 (4)0.033 (4)0.029 (4)0.007 (3)0.008 (3)0.004 (3)
C80.022 (4)0.018 (4)0.026 (4)0.005 (3)0.010 (3)0.002 (3)
C90.021 (4)0.016 (3)0.020 (3)0.001 (3)0.001 (3)0.000 (3)
C100.024 (4)0.023 (4)0.025 (4)0.003 (3)0.008 (3)0.003 (3)
C110.030 (4)0.021 (4)0.026 (4)0.001 (3)0.009 (3)0.004 (3)
Geometric parameters (Å, º) top
Br1—C101.944 (7)C4—C91.417 (9)
Br3—C111.948 (7)C5—C61.404 (11)
Br2—C111.910 (8)C6—C71.345 (10)
Cl1—C11.776 (7)C6—H60.9500
N1—C11.286 (10)C7—C81.419 (10)
N1—C51.371 (9)C7—H70.9500
C1—C21.416 (10)C8—C91.343 (10)
C2—C31.352 (10)C8—C111.489 (10)
C2—C101.478 (10)C9—H90.9500
C3—C41.409 (10)C10—H10A0.9900
C3—H30.9500C10—H10B0.9900
C4—C51.409 (10)C11—H111.0000
C1—N1—C5117.8 (6)C6—C7—H7119.7
N1—C1—C2126.0 (6)C8—C7—H7119.7
N1—C1—Cl1114.6 (5)C9—C8—C7119.9 (7)
C2—C1—Cl1119.5 (5)C9—C8—C11119.4 (7)
C3—C2—C1116.6 (6)C7—C8—C11120.7 (7)
C3—C2—C10121.5 (6)C8—C9—C4121.2 (6)
C1—C2—C10121.9 (6)C8—C9—H9119.4
C2—C3—C4120.5 (6)C4—C9—H9119.4
C2—C3—H3119.8C2—C10—Br1111.0 (5)
C4—C3—H3119.8C2—C10—H10A109.4
C5—C4—C3118.0 (6)Br1—C10—H10A109.4
C5—C4—C9118.2 (6)C2—C10—H10B109.4
C3—C4—C9123.8 (6)Br1—C10—H10B109.4
N1—C5—C6119.2 (6)H10A—C10—H10B108.0
N1—C5—C4121.2 (6)C8—C11—Br2113.3 (5)
C6—C5—C4119.6 (6)C8—C11—Br3111.2 (5)
C7—C6—C5120.5 (7)Br2—C11—Br3107.9 (3)
C7—C6—H6119.8C8—C11—H11108.1
C5—C6—H6119.8Br2—C11—H11108.1
C6—C7—C8120.6 (7)Br3—C11—H11108.1
C5—N1—C1—C20.4 (11)N1—C5—C6—C7178.3 (7)
C5—N1—C1—Cl1178.6 (5)C4—C5—C6—C70.2 (11)
N1—C1—C2—C30.7 (11)C5—C6—C7—C80.5 (12)
Cl1—C1—C2—C3178.3 (5)C6—C7—C8—C90.4 (12)
N1—C1—C2—C10180.0 (7)C6—C7—C8—C11178.8 (7)
Cl1—C1—C2—C101.0 (9)C7—C8—C9—C40.5 (11)
C1—C2—C3—C40.2 (10)C11—C8—C9—C4177.9 (6)
C10—C2—C3—C4179.1 (6)C5—C4—C9—C81.2 (10)
C2—C3—C4—C51.2 (10)C3—C4—C9—C8179.4 (7)
C2—C3—C4—C9179.4 (7)C3—C2—C10—Br1103.9 (7)
C1—N1—C5—C6178.7 (7)C1—C2—C10—Br176.8 (8)
C1—N1—C5—C40.7 (10)C9—C8—C11—Br2131.1 (6)
C3—C4—C5—N11.5 (10)C7—C8—C11—Br250.5 (8)
C9—C4—C5—N1179.1 (6)C9—C8—C11—Br3107.2 (7)
C3—C4—C5—C6179.5 (7)C7—C8—C11—Br371.3 (8)
C9—C4—C5—C61.0 (10)
Hydrogen-bond geometry (Å, º) top
Cg2 is the centroid of the C4–C9 ring.
D—H···AD—HH···AD···AD—H···A
C11—H11···Br1i1.002.923.709 (8)137
C10—H10B···Cg2ii0.992.703.438 (8)131
Symmetry codes: (i) x1/2, y+1/2, z1/2; (ii) x+1, y+1, z+1.
Hydrogen-bond geometry (Å, º) top
Cg2 is the centroid of the C4–C9 ring.
D—H···AD—HH···AD···AD—H···A
C11—H11···Br1i1.002.923.709 (8)137
C10—H10B···Cg2ii0.992.703.438 (8)131
Symmetry codes: (i) x1/2, y+1/2, z1/2; (ii) x+1, y+1, z+1.
 

Acknowledgements

HAS is grateful to the Leverhulme Trust and Durham University for financial support.

References

First citationChauhan, P. M. S. & Srivastava, S. K. (2001). Curr. Med. Chem. 8, 1535–1542.  CrossRef PubMed CAS Google Scholar
First citationChen, Y. L., Fang, K. C., Sheu, J. Y., Hsu, S. L. & Tzeng, C. C. (2001). J. Med. Chem. 44, 2374–2377.  Web of Science CrossRef PubMed CAS Google Scholar
First citationFerrarini, P. L., Mori, C., Badawneh, M., Calderone, V., Greco, R., Manera, C., Martinelli, A., Nieri, P. & Saccomanni, G. (2000). Eur. J. Med. Chem. 35, 815–826.  CrossRef PubMed CAS Google Scholar
First citationJones, G. (1977). Quinolines, Part-I. Wiley Interscience Publication, John Wiley & Sons.  Google Scholar
First citationLyle, R. E., Portlock, D. E., Kane, M. J. & Bristol, J. A. (1972). J. Org. Chem. 37, 3967–3968.  CrossRef CAS Google Scholar
First citationMacrae, C. F., Bruno, I. J., Chisholm, J. A., Edgington, P. R., McCabe, P., Pidcock, E., Rodriguez-Monge, L., Taylor, R., van de Streek, J. & Wood, P. A. (2008). J. Appl. Cryst. 41, 466–470.  Web of Science CSD CrossRef CAS IUCr Journals Google Scholar
First citationOxford Diffraction (2010). CrysAlis PRO. Oxford Diffraction Ltd, Yarnton, England.  Google Scholar
First citationSahin, A., Cakmak, O., Demirtas, I., Okten, S. & Tutar, A. (2008). Tetrahedron, 64, 10068–10074.  CrossRef CAS Google Scholar
First citationSheldrick, G. M. (2008). Acta Cryst. A64, 112–122.  Web of Science CrossRef CAS IUCr Journals Google Scholar
First citationSheldrick, G. M. (2015). Acta Cryst. C71, 3–8.  Web of Science CrossRef IUCr Journals Google Scholar
First citationSpek, A. L. (2009). Acta Cryst. D65, 148–155.  Web of Science CrossRef CAS IUCr Journals Google Scholar

This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.

Journal logoCRYSTALLOGRAPHIC
COMMUNICATIONS
ISSN: 2056-9890
Follow Acta Cryst. E
Sign up for e-alerts
Follow Acta Cryst. on Twitter
Follow us on facebook
Sign up for RSS feeds